Skip to main content
VCbacked
Log inGet Started

Atalanta Therapeutics

Boston, United States

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.

$97.0M raised
Jan 2025
Series B
BiotechnologyHealth CareLife Science

Top Investors

EQT Life SciencesSanofi VenturesF-PrimeAberdeenPictet Alternative Advisors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Atalanta Therapeutics

How much funding has Atalanta Therapeutics raised?
Atalanta Therapeutics has raised $97.0M in total funding. The most recent round was Series B. The last funding was announced in January 2025.
Who are Atalanta Therapeutics's investors?
Atalanta Therapeutics's investors include EQT Life Sciences, Sanofi Ventures, F-Prime, Aberdeen, Pictet Alternative Advisors.
Where is Atalanta Therapeutics headquartered?
Atalanta Therapeutics is headquartered in Boston, United States.
What does Atalanta Therapeutics do?
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
What stage is Atalanta Therapeutics at?
Atalanta Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Atalanta Therapeutics — Funding & Investors." VCBacked, January 28, 2025, https://www.vcbacked.co/company/atalanta-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2025). Atalanta Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/atalanta-therapeutics
Wikipedia (cite web)
{{cite web |title=Atalanta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/atalanta-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K